Furthermore, recent reports have suggested that amyloid-β synergistically interacts with tau to determine disease progression [45, 46], supporting a framework in which Alzheimer’s disease is characterized by multiple pathological interactions rather than the sequential aggregation of different pathologies. Here, MAPT is linked to Alzheimer disease.